ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2276

The Association of Knee Pain and Knee Osteoarthritis with Incident Widespread Pain: The Multicenter Osteoarthritis (MOST) Study

Lisa Carlesso1,2, Neil Segal3, Jeffrey R. Curtis4, Barton L. Wise5, Laura Frey-Law6, Michael C. Nevitt7, Anyu Hu8 and Tuhina Neogi9, 1School of Rehabiliation, Maisonneuve Rosemont Research Institute, Université de Montréal, Montreal, QC, Canada, 2Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 3University of Kansas, Shawnee, KS, 4Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Int Medicine, UCDMC, Sacramento, CA, 6UIowa, Iowa City, IA, 7Epidemiology and Biostatistics, UCSF, San Francisco, CA, 8Clinical Epidemiology Research Unit, Boston University School of Medicine, Boston, MA, 9Clinical Epidemiology, BUSM, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Knee and OA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Epidemiology and Public Health Poster (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Widespread
pain (WSP) is associated with morbidity, and poor mental and physical
functioning, but its etiology is not well understood. It has been hypothesized
that painful peripheral pathology may result in WSP. Previous cross-sectional
studies have shown an association of knee pain and radiographic knee osteoarthritis
(ROA) with WSP.  However, the independent
relations of knee OA and knee pain, to incident WSP is unknown. We examined the
relation of ROA, symptomatic knee OA (SxOA) and
consistent frequent knee pain (CFKP) to incident WSP in a large prospective
cohort.

Methods:  We
used data from the Multicenter
Osteoarthritis (MOST) Study, a NIH-funded longitudinal prospective
cohort of 3026 older adults with or at risk of knee OA. ROA was defined as
having radiographic tibiofemoral OA (Kellgren & Lawrence grade ≥2) on the 60-month
radiographs. The definition of CFKP was met if a participant reported knee pain
on most days during the past month at the 60-month telephone interview and at
the clinic visit that occurred on average one month later. SxOA
was defined as having both ROA and CFKP at 60 months. We also considered knee
replacement as equivalent to ROA and SxOA.
WSP was defined as pain above and below the waist, on both
sides of the body and axially, using a standard homunculus, excluding knee pain.
Incident WSP was defined as presence of WSP at 84 months among those who were free
of WSP at 60 months. We assessed the relation of baseline ROA, SxOA,
and CFKP, respectively, to incident WSP using logistic regression,
adjusting for baseline age, sex, BMI, comorbidities, physical activity, WOMAC pain
intensity, study site, depressive symptoms, pain catastrophizing and fatigue.

Results:   At baseline, 1309 subjects were
eligible for ROA analysis (age mean, SD; 67.3, 7.8; BMI 30.5, 6.0 kg/m2,
56% women), 1316 for SxOA analysis (age 67.3, 7.8; BMI 30.4, 5.9 kg/m2,
55% women) and 1383
for CFKP analysis (age 67.4, 7.8; BMI 30.5, 6.0 kg/m2, 55%
women). Baseline
presence of unilateral ROA was associated with a non-significant 30% lower risk
of incident WSP compared with those without ROA (adjusted OR 0.70, 95% CI
0.46-1.07, p=0.10). Similar results were found for those with bilateral ROA. Similarly,
neither baseline unilateral nor bilateral SxOA were associated with risk of incident WSP compared with
those without SxOA. Baseline presence of unilateral CFKP
was also not significantly associated with incident WSP, while bilateral CFKP approached
significance (see table).

Conclusion: Neither
ROA, SxOA nor CFKP increased the risk of developing WSP.
These results suggest that neither knee joint pathology nor joint pain are major
factors in the onset of WSP. Further study is required to clarify what factors
contribute to the onset of WSP.

Table: Risk of ROA, SxOA and CFKP
to incident widespread pain

ROA at baseline

SxOA at baseline

CFKP at baseline

# of knees

N of

subjects

Risk of incident WSP N (%)

Adjusted OR*

N of

subjects

Risk of incident WSP N (%)

Adjusted OR*

N of

subjects

Risk of incident WSP N (%)

Adjusted OR*

None

486

72 (14.8%)

1.0

1079

152 (14.1%)

1.0

1018

131 (12.9%)

1.0

Unilateral

365

56 (15.3%)

0.70 (0.46, 1.07) p=0.10

172

38 (22.1%)

0.92 (0.57, 1.48) p=0.72

223

49 (22.0%)

1.30 (0.84, 2.00)

p=0.23

Bilateral

458

83 (18.1%)

0.75 (0.50, 1.12) p=0.16

65

19 (29.2%)

1.25 (0.65, 2.39) p=0.51

142

40 (28.1%)

1.59 (0.97, 2.61)

p=0.07

[*] Adjusting for age at 60 mo, sex, BMI, comorbidities, physical activity
at 60 mo, clinic site, CES-D, catastrophizing, sleep/fatigue, knee pain severity.


Disclosure: L. Carlesso, None; N. Segal, None; J. R. Curtis, Roche/Genentech, UCB, Janssen, CORRONA, Amgen, Pfizer, BMS, Crescendo, AbbVie, 2,Roche/Genentech, UCB, Janssen, CORRONA, Amgen, Pfizer, BMS, Crescendo, AbbVie, 5; B. L. Wise, None; L. Frey-Law, None; M. C. Nevitt, None; A. Hu, None; T. Neogi, None.

To cite this abstract in AMA style:

Carlesso L, Segal N, Curtis JR, Wise BL, Frey-Law L, Nevitt MC, Hu A, Neogi T. The Association of Knee Pain and Knee Osteoarthritis with Incident Widespread Pain: The Multicenter Osteoarthritis (MOST) Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-association-of-knee-pain-and-knee-osteoarthritis-with-incident-widespread-pain-the-multicenter-osteoarthritis-most-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-knee-pain-and-knee-osteoarthritis-with-incident-widespread-pain-the-multicenter-osteoarthritis-most-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology